Archive
Proactive news snapshot: Scancell Holdings, Mosman Oil And Gas, InnovaDerma …
A glance at some of the day's highlights from the Proactive Investors newswire
Company
Scancell Holdings PLC
LON:SCLP
Scancell is a clinical stage biotech company developing immunotherapies for a cancer-free future by enhancing long-lasting tumour specific immunity. With deep roots in cancer immunology and translational research, the company aims to translate its innovation and creativity to address the need for fast, potent and accessible therapies that are easy to administer in hard-to-treat cancers.
329 stories · page 11 of 17
LiDCO shares fall after saying it expects 2017 loss
A look at some of today's top risers and fallers in London today
Scancell to work with Dutch firm on first product for Moditope cancer immuno-therapy platform
Dutch group ISA Pharmaceutical will incorporate its Amplivant technology into Modi-1, the first cancer treatment candidate being developed on the platform
Investments and investor services
FTSE 100 closes up, boosted by mining stocks and as pound strengthens against the dollar
The UK's blue-chip index closes up 20.84 points to 7,234.81
Archive
Proactive news snapshot: Oracle Power, Anglo Asian Mining, 88 Energy …
A glance at some of the day's highlights from the Proactive Investors newswire
Scancell drug receives positive write-up in leading journal as company updates on survival data
Immuno-therapy SCIB1, which is expected to progress into Phase II clinical trials in the second-half of the year, was the focus of a peer-reviewed paper in OncoImmunology
Investments and investor services
FTSE 100 heats up as defensives are given the cold shoulder
The index of blue-chip shares eased off a little in the final half-hour
Archive
Rough week for Wall Street makes life tough for investors in UK small-caps
While the blue-chips were shaken, with a fall of 3.8% over the trading week, shares in the UK’s growth sector were even harder hit with the AIM All Share off 4.5%
Archive
Breakfast News -
Archive
Proactive news snapshot: Scancell, Bacanora Minerals, S & U …
A glance at some of the day's highlights from the Proactive Investors newswire
Ohhhh yes! Direct Line's trading update provides insurer with a lift
A look at some of the biggest risers and fallers in London on Friday
Scancell to receive patent protection for key cancer platform
Once formally granted, the patent will provide protection for Scancell’s pipeline of Moditope vaccines
FTSE 100's losses lengthen as US markets move back into reverse
The US rally fizzled out prompting a late sell-off in an already below-water London
Archive
Proactive news snapshot: Flying Brands Limited, Seeing Machines, Thor Mining, 88 Energy ...
A glance at some of the day's highlights from the Proactive Investors newswire
Flying Brands lifts off as it confirms advanced talks regarding a North American acquisition
A look at some of the biggest risers and falls on the London market today
Scancell-led team short-listed for award
The Cancer Research UK Grand Challenge is a prestigious award that brings with it significant funding
Investments and investor services
FTSE 100 closes firmly lower as strong pound weighs
The FTSE 100 index – which is chock full of dollar earners – closed around 108 points lower at 7,170
Archive
Proactive news snapshot: IXICO, Ferrum Crescent, Goldplat …
A glance at some of the day's highlights from the Proactive Investors newswire
PCI-PAL cashes in on recent share price surge as it raises £5mln at a discount
Some of the main news-driven risers and fallers in London on Tuesday...
Scancell eyeing investigational new drug application for SCIB1 in first half
Patient enrolment for the SCIB1 Phase 2 checkpoint inhibitor combination study for patients with advanced melanoma is planned to start in the second half of the year